{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-000098","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2023-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.427790+00:00","generated_at":"2026-06-20T18:46:15.094320+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Phio Pharmaceuticals stockholders approve reverse stock split; ratio up to 1:25","bullets":["Stockholders approved reverse stock split at ratio between 1:2 and 1:25; board to set exact ratio and effective date.","Vote results: 19,728,800 For, 4,120,599 Against, 150,982 Abstain.","Special meeting held January 4, 2023; record date November 17, 2022.","Company also posted updated investor presentation on its website on January 6, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-000098","json":"https://secwatch.observer/filing/0001683168-23-000098.json","markdown":"https://secwatch.observer/filing/0001683168-23-000098.md","text":"https://secwatch.observer/filing/0001683168-23-000098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316823000098/0001683168-23-000098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316823000098/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T18:46:15.094320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e68f6e259593241b531f40d385a552a6ded06e71","claim":"Phio Pharmaceuticals Corp. shareholders approved Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25 at the 2023-01-04 meeting.","evidence_excerpt":"The Reverse Stock Split Proposal submitted to a vote of the Company’s stockholders at the Special Meeting was approved.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316823000098/0001683168-23-000098-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-01-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}